BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
7 Strange Devices to Make Your Party Stick Out! - 2Saturn shines with the waxing moon at sunset on Nov. 29
- 3Vote in favor of your Number one method for praising a birthday
- 4Incredible Travel Objections for Craftsmanship Darlings to Visit
- 5Newly discovered link between traumatic brain injury in children and epigenetic changes could help personalize treatment for recovering kids
- Kennedy approves adding two rare disorders to newborn screenings
- Paraplegic engineer becomes the first wheelchair user to blast into space
- Cyber Monday streaming deals 2025: Grab the Disney+ Hulu bundle for only $5 and save over 60%
- NASA is sending astronauts back to the moon. Can you see the Artemis 4 landing sites from Earth?
- We may have less control over how long we live than previously thought
- I'm an 83-year-old yoga instructor. I'm not your typical grandma — I still work to feel fulfilled and supplement my Social Security.
- Holiday spots Well known With Americans In 2024
- One-third of asylum applications by Iranians approved in Germany
- Holiday weather forecast: Where travelers can expect a wintry mix, flooding and record warmth across the U.S.
